1. Parasympathetic, but not sympathetic denervation, suppressed colorectal cancer progression.
- Author
-
Sadighparvar S, Darband SG, Ghaderi-Pakdel F, Mihanfar A, and Majidinia M
- Subjects
- 1,2-Dimethylhydrazine administration & dosage, 1,2-Dimethylhydrazine toxicity, Animals, Carcinogenesis chemically induced, Carcinogens administration & dosage, Carcinogens toxicity, Colon innervation, Colon pathology, Colorectal Neoplasms chemically induced, Colorectal Neoplasms pathology, Disease Progression, Ganglia, Sympathetic drug effects, Ganglia, Sympathetic surgery, Ganglionectomy, Guanethidine administration & dosage, Humans, Male, Mesentery innervation, Neoplasms, Experimental chemically induced, Neoplasms, Experimental pathology, Parasympathetic Nervous System drug effects, Parasympathetic Nervous System surgery, Rats, Rats, Wistar, Atropine administration & dosage, Colorectal Neoplasms surgery, Neoplasms, Experimental surgery, Vagotomy
- Abstract
Disruption in the nerve-tumor interaction is now considered as a possible anticancer strategy for treating various cancer types, particularly colorectal cancer. However, the underlying mechanisms are not still fully understood. Therefore, the present study aimed to evaluate the effects of sympathetic and parasympathetic denervation on the inhibition of colorectal cancer progression in early and late phases and assess the involvement of nerve growth factor in denervation mediated anticancer effects. One-hundred and fifty male Wistar rats were assigned into 15 groups. Seven groups comprising the control group, 1,2-dimethylhydrazine (DMH) group, sympathetic denervation group (celiac-mesenteric ganglionectomy and guanethidine sulphate administration), parasympathetic denervation group (vagotomy and atropine administration), and combination group were used in the early-stage protocol. For the late-stage protocol, eight groups comprising the control, DMH, surgical and pharmacological sympathetic and parasympathetic denervation groups, combination group, and 5-flourouracil group were considered. After 8 weeks, sympathetic and parasympathetic denervation significantly reduced ACF numbers in rats receiving DMH. On the other hand, in the late stages, parasympathetic but not sympathetic denervation resulted in significant reductions in tumor incidence, tumor volume and weight, cell proliferation (indicated by reduced immunostaining of PCNA and ki-67), and angiogenesis (indicated by reduced immunostaining of CD31 and VEGF expression levels), and downregulated NGF, β2 adrenergic, and M3 receptors. It can be concluded that parasympathetic denervation may be of high importance in colon carcinogenesis and suggested as a possible therapeutic modality in late stages of colorectal cancer., (Copyright © 2021 Elsevier B.V. All rights reserved.)
- Published
- 2021
- Full Text
- View/download PDF